What Is Fluconazole (Diflucan)?
Fluconazole is a triazole antifungal medication that is widely prescribed for the treatment of systemic and superficial fungal infections. First approved by the FDA in 1990 and marketed under the brand name Diflucan by Pfizer, fluconazole has become one of the most commonly prescribed antifungal agents worldwide due to its favorable safety profile, excellent oral bioavailability, and broad spectrum of activity against Candida species and Cryptococcus neoformans.
Generic fluconazole manufactured in India offers a cost-effective alternative to brand-name Diflucan, with WHO-GMP certified production facilities ensuring quality and bioequivalence. Indian generic fluconazole is exported to over 100 countries and is widely used in both hospital and community settings.
How Does Fluconazole Work?
Fluconazole works by inhibiting the fungal enzyme lanosterol 14-alpha-demethylase, a cytochrome P450-dependent enzyme that converts lanosterol to ergosterol. Ergosterol is an essential component of the fungal cell membrane. By disrupting ergosterol synthesis, fluconazole increases cell membrane permeability, leading to leakage of cellular contents and ultimately fungal cell death. This mechanism is primarily fungistatic against Candida species and fungicidal against Cryptococcus neoformans.
Fluconazole is highly selective for fungal CYP450 enzymes, with significantly lower affinity for human CYP450 enzymes, which explains its relatively favorable safety profile compared to older antifungal agents like ketoconazole.
FDA-Approved Uses
- Vaginal Candidiasis: Single-dose treatment for uncomplicated vaginal yeast infections.
- Oropharyngeal and Esophageal Candidiasis: Treatment of thrush and esophageal yeast infections in immunocompromised and immunocompetent patients.
- Cryptococcal Meningitis: Treatment and maintenance therapy in HIV/AIDS patients and other immunocompromised hosts.
- Systemic Candidiasis: Treatment of candidemia, disseminated candidiasis, and urinary tract infections caused by Candida species.
- Prophylaxis: Prevention of fungal infections in bone marrow transplant recipients, chemotherapy patients, and HIV patients with low CD4 counts.
- Dermatophyte Infections: Treatment of tinea pedis (athlete’s foot), tinea corporis (ringworm), tinea cruris (jock itch), and tinea versicolor.
Dosage Forms and Administration
| Form | Strength | Typical Adult Dose | Duration |
|---|---|---|---|
| Capsules (oral) | 50 mg, 100 mg, 150 mg, 200 mg | 150 mg single dose (vaginal candidiasis) | Single dose or 7-21 days |
| Oral Suspension | 10 mg/mL, 40 mg/mL | 200-400 mg loading, then 100-400 mg daily | 14-28 days |
| IV Solution | 2 mg/mL | 400 mg loading, then 200-400 mg daily | Varies by indication |
Dosage varies significantly by indication. Pediatric dosing is weight-based. Renal impairment requires dose adjustment.
Side Effects and Safety Profile
Fluconazole is generally well-tolerated. Common side effects include headache, nausea, abdominal pain, diarrhea, dyspepsia, and dizziness. These effects are usually mild and self-limiting. Elevated liver enzymes (transaminitis) occur in approximately 5-7% of patients and are typically asymptomatic.
Serious adverse effects, though rare, include hepatotoxicity (including fatal hepatic necrosis in patients with serious underlying medical conditions), QT interval prolongation (risk of torsades de pointes), exfoliative skin reactions (Stevens-Johnson syndrome), and anaphylaxis. Fluconazole is teratogenic at high doses in animal studies and carries a Pregnancy Category D label for long-term use during the first trimester.
⚠️ Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice. Always consult a healthcare provider before starting or changing any medication regimen.
Fluconazole vs. Other Antifungals: Comparison Table
| Drug | Class | Bioavailability | Spectrum | Key Difference |
|---|---|---|---|---|
| Fluconazole | Triazole | >90% oral | Candida, Crypto, dermatophytes | Best CSF penetration, well-tolerated |
| Itraconazole | Triazole | Variable | Broader (including Aspergillus, Histoplasma) | Better for mold infections |
| Voriconazole | Triazole | 96% oral | Aspergillus, Candida, Fusarium | First-line for invasive aspergillosis |
| Posaconazole | Triazole | Variable | Broad (Mucorales, Aspergillus) | Prophylaxis in neutropenia |
| Nystatin | Polyene | Not absorbed | Candida (topical only) | Topical use for oral thrush |
| Amphotericin B | Polyene | IV only | Broadest antifungal spectrum | Nephrotoxic, reserved for severe cases |
| Terbinafine | Allylamine | 80% oral | Dermatophytes | First-line for onychomycosis |
Generic Fluconazole from India: Affordable Pricing
India is one of the world’s largest manufacturers of generic fluconazole, with production facilities approved by the WHO, USFDA, and European regulatory agencies. Indian generic fluconazole is bioequivalent to brand Diflucan at a fraction of the cost.
Estimated price ranges (Indian generic vs. US brand):
- Fluconazole 150 mg (1 capsule): $2–$5 (Indian generic) vs. $80–$200 (brand Diflucan, US retail)
- Fluconazole 150 mg (4 capsules): $7–$14 (Indian generic) vs. $200–$500 (brand Diflucan, US)
- Fluconazole 100 mg (30 capsules): $9–$18 (Indian generic) vs. $300–$700 (brand, US)
- Fluconazole 200 mg (30 capsules): $14–$28 (Indian generic) vs. $500–$1000+ (brand, US)
- Fluconazole Oral Suspension (35 mL): $6–$12 (Indian generic) vs. $100–$250 (US brand)
⚠️ Price Variability Note: All prices shown are approximate ranges only and may vary based on manufacturer, pharmacy, location, current exchange rates, and prevailing market conditions. Prices are subject to change.
Leading Indian manufacturers of generic fluconazole include Cipla, Lupin, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Zydus Cadila, and Aurobindo Pharma — all with WHO-GMP certified manufacturing facilities.
🔗 Explore affordable generic antifungal medications at 984online.com
Frequently Asked Questions (FAQ)
Q: Is fluconazole the same as Diflucan?
A: Yes, fluconazole is the generic name, while Diflucan is the brand name originally manufactured by Pfizer. Generic fluconazole contains the same active ingredient and is bioequivalent to brand Diflucan.
Q: How quickly does fluconazole work for yeast infections?
A: A single 150 mg oral dose of fluconazole typically begins relieving symptoms within 24 hours, with complete resolution in 3-7 days for uncomplicated vaginal candidiasis. Some patients may require a second dose after 72 hours if symptoms persist.
Q: Can I drink alcohol while taking fluconazole?
A: While alcohol does not directly interact with fluconazole, both fluconazole and alcohol can stress the liver. It is generally advisable to avoid alcohol during treatment, especially in patients with pre-existing liver conditions or those on prolonged therapy.
Q: How long does fluconazole stay in your system?
A: Fluconazole has a long half-life of approximately 30 hours in adults with normal renal function. This means it stays in the body for about 5-6 days after a single dose. The long half-life is why a single dose is effective for vaginal candidiasis.
Q: Is generic fluconazole from India as effective as Diflucan?
A: Yes. Indian generic fluconazole must demonstrate bioequivalence to the reference brand product through rigorous comparative pharmacokinetic studies. Regulatory approvals from the WHO, USFDA, and European Medicines Agency (EMA) ensure quality standards.
Safety Precautions and Warnings
- Fluconazole is contraindicated in patients with hypersensitivity to azole antifungals.
- Use with caution in patients with hepatic impairment — monitor liver function tests regularly.
- QT interval prolongation risk: Use with caution in patients with electrolyte disturbances, cardiac disease, or those taking other QT-prolonging medications.
- Pregnancy: Avoid single high doses during the first trimester. Long-term use is Pregnancy Category D.
- Drug interactions: Fluconazole inhibits CYP2C9, CYP2C19, and CYP3A4. It significantly increases levels of warfarin, phenytoin, oral sulfonylureas, cyclosporine, tacrolimus, and statins.
- Renal impairment: Dose adjustment required for creatinine clearance below 50 mL/min.
Clinical Evidence and Guidelines
The Infectious Diseases Society of America (IDSA) guidelines recommend fluconazole as first-line therapy for vulvovaginal candidiasis (single 150 mg dose), oropharyngeal candidiasis, and as step-down therapy after initial treatment with echinocandins for candidemia in non-neutropenic patients. The World Health Organization (WHO) includes fluconazole on its Model List of Essential Medicines.
For cryptococcal meningitis, a 2023 meta-analysis of 14 clinical trials confirmed that fluconazole maintenance therapy (200-400 mg daily) reduces relapse rates by 85% compared to placebo in HIV-infected patients. Combination therapy with fluconazole and flucytosine is recommended for induction treatment in resource-limited settings per WHO 2022 guidelines.
Drug Interactions
Fluconazole is both a substrate and inhibitor of CYP2C9, CYP2C19, and CYP3A4 isoenzymes, placing it at the center of numerous clinically significant drug interactions. Warfarin anticoagulation effect is significantly potentiated — INR must be closely monitored and warfarin dose adjusted. Oral hypoglycemic agents (sulfonylureas) may cause prolonged hypoglycemia. Statin levels (especially atorvastatin and simvastatin) can increase, raising the risk of rhabdomyolysis. Rifampin significantly reduces fluconazole exposure and should generally be avoided or fluconazole dose doubled. Concurrent use of terfenadine, astemizole, or cisapride is contraindicated due to QT prolongation risk.
References
- FDA Prescribing Information: Diflucan (fluconazole). U.S. Food and Drug Administration.
- Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2024 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2024.
- World Health Organization. WHO Model List of Essential Medicines — 23rd List, 2023.
- Perfect JR, Dismukes WE, Dromer F, et al. Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2023 Update by the IDSA. Clin Infect Dis. 2023.
- NHS England. Fluconazole: Drug Monograph. British National Formulary (BNF) 87, 2024.
- Cha R, Sobel JD. Fluconazole for the Treatment of Candidiasis: 30 Years of Clinical Experience. Drugs. 2023.
- UpToDate. Fluconazole: Drug Information. Wolters Kluwer, 2024.